- -

Assessment of the Inter-Batch Variability of Microstructure Parameters in Topical Semisolids and Impact on the Demonstration of Equivalence

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

Assessment of the Inter-Batch Variability of Microstructure Parameters in Topical Semisolids and Impact on the Demonstration of Equivalence

Mostrar el registro sencillo del ítem

Ficheros en el ítem

dc.contributor.author Mangas-Sanjuan, Victor es_ES
dc.contributor.author Pleguezuelos-Villa, María es_ES
dc.contributor.author Merino-Sanjuán, Matilde es_ES
dc.contributor.author Hernández, Mª Jesús es_ES
dc.contributor.author Nácher, Amparo es_ES
dc.contributor.author García-Arieta, Alfredo es_ES
dc.contributor.author Peris, Daniel es_ES
dc.contributor.author Hidalgo, Irene es_ES
dc.contributor.author Soler, Lluís es_ES
dc.contributor.author Sallan, Marta es_ES
dc.contributor.author Merino, Virginia es_ES
dc.date.accessioned 2023-04-27T18:01:24Z
dc.date.available 2023-04-27T18:01:24Z
dc.date.issued 2019-10 es_ES
dc.identifier.uri http://hdl.handle.net/10251/193002
dc.description.abstract [EN] Demonstration of similar microstructure is essential for demonstrating the equivalence of generic topical products since the microstructure of semisolids may affect the drug release. The objective of this study was to compare the microstructure-defining physical parameters of different batches of a reference ointment containing calcipotriol and betamethasone (Daivobet 50 mu g/0.5 mg/g) in order to define the acceptance range that allows concluding equivalence between these batches. Being batches of the same reference product, they are expected to be clinically equivalent and possess similar microstructure. The 90% confidence intervals for the test/reference ratio of these physical parameters were calculated with parametric and non-parametric approaches. Both methods conclude that equivalent microstructure between batches cannot be demonstrated with a reasonable sample size when the acceptance range was set at +/- 10%, since several physical parameters exhibit inter-batch variability >10%. An acceptance range of +/- 10% is therefore too strict to conclude equivalence in the microstructure of semisolid dosage forms, given the inter-batch variability observed between batches of the reference product. A wider fixed acceptance range or an acceptance range widened based on the inter-batch variability of the reference product would be advisable. es_ES
dc.description.sponsorship This work was supported by Kern Pharma S.L. (Spain). es_ES
dc.language Inglés es_ES
dc.publisher MDPI AG es_ES
dc.relation.ispartof Pharmaceutics es_ES
dc.rights Reconocimiento (by) es_ES
dc.subject Microstructure es_ES
dc.subject Rheology es_ES
dc.subject Equivalence es_ES
dc.subject Generic semisolid formulation es_ES
dc.subject Topical drug es_ES
dc.subject Inter-batch variability es_ES
dc.title Assessment of the Inter-Batch Variability of Microstructure Parameters in Topical Semisolids and Impact on the Demonstration of Equivalence es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.3390/pharmaceutics11100503 es_ES
dc.rights.accessRights Abierto es_ES
dc.description.bibliographicCitation Mangas-Sanjuan, V.; Pleguezuelos-Villa, M.; Merino-Sanjuán, M.; Hernández, MJ.; Nácher, A.; García-Arieta, A.; Peris, D.... (2019). Assessment of the Inter-Batch Variability of Microstructure Parameters in Topical Semisolids and Impact on the Demonstration of Equivalence. Pharmaceutics. 11(10):1-12. https://doi.org/10.3390/pharmaceutics11100503 es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion https://doi.org/10.3390/pharmaceutics11100503 es_ES
dc.description.upvformatpinicio 1 es_ES
dc.description.upvformatpfin 12 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 11 es_ES
dc.description.issue 10 es_ES
dc.identifier.eissn 1999-4923 es_ES
dc.identifier.pmid 31581492 es_ES
dc.identifier.pmcid PMC6835722 es_ES
dc.relation.pasarela S\403335 es_ES
dc.contributor.funder Kern Pharma, S.L. es_ES


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem